Publication of Accounts
The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014, as retained as part of the law of England and Wales. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.
20 December 2023
Pharma C Investments PLC
("Pharma C" or the "Company")
Publication of Accounts
Pharma C (AQSE: PCIL) is pleased to announce the publication of its audited financial statements for the year ended 31 December 2022 which are available to view and download from the Investor Relations section of the Company's website at https://www.pharmacinvestments.com/investors/reports-presentations. The Company will call its Annual General Meeting in due course.
The Directors of Pharma C take responsibility for this announcement.
For further information please visit www.pharmacinvestments.com
|
Pharma C Investments |
|
|
Gavin Sathianathan |
Via First Sentinel |
|
First Sentinel Corporate Finance |
|
|
Brian Stockbridge, Corporate Adviser
|
+44 20 3855 5551 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 1 day ago Cambridge Cognition Holdings
- 1 day ago Shell
- 1 day ago Centrica
- 1 day ago Optima Health
- 1 day ago Centrica